Zobrazeno 1 - 10
of 74
pro vyhledávání: '"David J R Foster"'
Publikováno v:
PLoS ONE, Vol 12, Iss 6, p e0178783 (2017)
Cats are the most common mammal to develop invasive fungal rhinosinusitis caused by cryptic species in Aspergillus section Fumigati that are resistant to azoles but susceptible to caspofungin. In this study nonlinear mixed-effects pharmacokinetic mod
Externí odkaz:
https://doaj.org/article/d7273d7a59b941fba84104e40c54e3de
Autor:
Ahmad Y. Abuhelwa, David J. R. Foster, Arkady Manning-Bennett, Michael J. Sorich, Susanna Proudman, Michael D. Wiese, Ashley M. Hopkins
Publikováno v:
Therapeutic Advances in Musculoskeletal Disease, Vol 13 (2021)
Background: Rheumatoid arthritis (RA) is a chronic inflammatory autoimmune disease associated with increased risk of cardiovascular disease (CVD). Treatment for CVD may involve pharmacological agents that antagonise beta adrenergic receptors. These r
Externí odkaz:
https://doaj.org/article/44171b33973a47feb71abaeba9bbbccd
Autor:
Asbjørn Mohr Drewes, Grzegorz J. Pacyk, Jens Peter Kroustrup, Kenneth T. Kongstad, David J. R. Foster, Ahmad Y. Abuhelwa, Lona L. Christrup, Louise Ladebo, Anne Estrup Olesen
Publikováno v:
Ladebo, L, Abuhelwa, A Y, Foster, D J R, Kroustrup, J P, Pacyk, G J, Kongstad, K T, Drewes, A M, Christrup, L L & Olesen, A E 2021, ' Effect of Roux-en-Y gastric bypass on the pharmacokinetic-pharmacodynamic relationships of liquid and controlled-release formulations of oxycodone ', Basic & Clinical Pharmacology & Toxicology, vol. 129, no. 3, pp. 232-245 . https://doi.org/10.1111/bcpt.13634
The physiological changes following Roux-en-Y gastric bypass (RYGB) surgery may impact drug release from mechanistically different controlled-release tablets, making generic substitution inappropriate. This study aimed to characterise the pharmacokin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::89b934d490e6e88500dc8fb6a9d66a46
https://hdl.handle.net/11541.2/148124
https://hdl.handle.net/11541.2/148124
Publikováno v:
Drug Delivery Approaches
Physiologically based pharmacokinetic (PBPK) models allow integrated representations of the time course of drug concentrations in the important organs and sites of drug action, toxicity, absorption, metabolism, and excretion. PBPK models have multipl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f0431008f115b11e39b6698ddbec6e7a
https://hdl.handle.net/11541.2/27124
https://hdl.handle.net/11541.2/27124
Autor:
Kenneth T. Kongstad, Richard N. Upton, Lona L. Christrup, Louise Ladebo, Asbjørn Mohr Drewes, Ahmad Y. Abuhelwa, David J. R. Foster, Anne Estrup Olesen
Publikováno v:
Ladebo, L, Foster, D J R, Abuhelwa, A Y, Upton, R N, Kongstad, K T, Drewes, A M, Christrup, L L & Olesen, A E 2020, ' Population pharmacokinetic-pharmacodynamic modelling of liquid and controlled-release formulations of oxycodone in healthy volunteers ', Basic & Clinical Pharmacology & Toxicology, vol. 126, no. 3, pp. 263-276 . https://doi.org/10.1111/bcpt.13330
Oral controlled-release formulations are playing an ever-increasing role in opioid therapy; however, little is known about their influence on the relationship between pharmacokinetics and pharmacodynamics. The study aim was to characterize the pharma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7a59a0ab7a24090ab38ae7a0a5ac00cc
https://vbn.aau.dk/da/publications/1bb1198a-dee9-4c3d-a70f-6cb9813410e4
https://vbn.aau.dk/da/publications/1bb1198a-dee9-4c3d-a70f-6cb9813410e4
Autor:
Trine Meldgaard Lund, Asbjørn Nøhr-Nielsen, Richard N. Upton, David J. R. Foster, Julie Lyng Forman, Ole J. Bjerrum, Theodoros Papathanasiou, Theis Lange
Exposure-response (ER) modeling for fixed-dose combinations (FDC) has previously been found to have an inflated false positive rate (FP), i.e., observing a significant effect of FDC components when no true effect exists. Longitudinal exposure-respons
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::492541a5a6461e303d35d3b87b547fdc
https://hdl.handle.net/11541.2/141328
https://hdl.handle.net/11541.2/141328
Publikováno v:
Journal of Pharmacokinetics and Pharmacodynamics. 45:181-197
The aim of this study was to develop a population in vitro–in vivo pharmacokinetic model that simultaneously describe the absorption and accumulation kinetics of itraconazole (ICZ) and hydroxy-itraconazole (HICZ) in healthy subjects. The model inte
Publikováno v:
Journal of Veterinary Cardiology. 18:310-325
Introduction To investigate the pharmacokinetics and pharmacodynamics of oral pimobendan in conscious, healthy cats. Animals Eight healthy adult cats. Materials and methods A randomised, single-blinded, crossover design was used. Two oral doses of pi
Autor:
Mitch A. Phelps, Stephanie E. Reuter, Darlene M. Rozewski, David J. R. Foster, Richard N. Upton, Jim H. Hughes
Publikováno v:
Cancer Chemother Pharmacol
Purpose: Lenalidomide is used widely in B-cell malignancies for its immunomodulatory activity. It is primarily eliminated via the kidneys, with a significant proportion of renal elimination attributed to active processes. Lenalidomide is a weak subst
Publikováno v:
The Journal of pharmacy and pharmacologyReferences. 71(11)
Objectives The selection of sample times for a pharmacokinetic study is important when trapezoidal integration (e.g. non-compartmental analysis) is used to determine the area under the concentration–time curve (AUC). The aim of this study was to de